Alan Askari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alan Askari has a total of 297 co-authors. Here are the top co-authors by number of shared publications:
Andrew Currie
Surgical Epidemiology, Trials and Outcome Centre (SETOC), St Mark's Hospital & Academic Institute, Harrow, Middlesex, HA1 3UJ, United Kingdom
9 shared publications- Ali Kordzadeh
Department of Vascular, Endovascular and Renal Access Surgery, Mid & South Essex NHS Foundation Trust, Basildon Hospital, Nether Mayne, Basildon SS16 5NL, Essex, UK
8 shared publications Omar Faiz
Surgical Epidemiology, Trials and Outcome Centre (SETOC) St Mark′s Hospital Harrow UK
8 shared publicationsAruna Munasinghe
Department of General Surgery, Luton & Dunstable Hospital , Luton , UK
7 shared publicationsSubramanian Nachiappan
St Mark's Hospital & Academic Institute, London, UK
7 shared publicationsVigyan Jain
Department of General Surgery, Luton & Dunstable Hospital , Luton , UK
7 shared publications
Latest Publications
- Open Access
- 28 November 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (1) , 215-225
The Effect of Increased Sodium Intake with a Carbohydrate-Rich Meal on Glucose Homeostasis in People without Diabetes after Roux-en-Y Gastric Bypass: a Proof-of-Concept, Randomized, Open-Label, Crossover Study
Introduction: Roux-en-Y gastric bypass (RYGB) induces substantial weight loss and changes in glucose homeostasis, partly through alterations in gastrointestinal anatomy and nutrient absorption. Sodium-glucose co-transporters-1 (SGLT-1) facilitate intestinal glucose absorption, a process that may be compromised post-RYGB. Animal studies suggest that sodium supplementation to a meal may enhance SGLT-1 activity post-RYGB. In this study, we investigated whether adding sodium chloride (NaCl) to a carbohydrate-rich meal affects glucose homeostasis in people after RYGB. Methods: In this open-label, randomized, crossover study, eleven adults without diabetes post-RYGB (mean age 57.3 ± 11.3 years, BMI 35.1 ± 7.5 kg/m2, 64% female) underwent two mixed meal tolerance tests (MMTT), on separate days, either with or without 2 g of additional NaCl (785 mg sodium). The primary outcome was the difference in nadir postprandial plasma glucose between conditions. Secondary outcomes included differences in area under the curve (AUC 0 − 180‘ ), fasting and peak plasma glucose, insulin, c-peptide and glucagon-like peptide-1 (GLP-1) concentrations. Results: The addition of 2 g NaCl did not alter nadir plasma glucose (3.7 mmol/L with NaCl vs 3.5 mmol/L without NaCl, 95% CI: -0.50 to 0.30, p = 0.55), fasting glucose or AUC 0 − 180’ glucose. However, peak plasma glucose was lower with NaCl (7.8 vs 8.3 mmol/L, 95% CI: -0.88 to -0.08, p = 0.02). No differences were observed in AUC 0 − 180’ , fasting and peak insulin, c-peptide and GLP-1 concentrations between the conditions. Conclusions: In individuals post-RYGB without diabetes, sodium supplementation during a carbohydrate-rich meal did not substantially affect glucose homeostasis, although it appeared to reduce peak postprandial plasma glucose. Further studies are warranted to explore the clinical relevance of this effect.
- 28 November 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 36 (1) , 215-225
Open AccessThe Effect of Increased Sodium Intake with a Carbohydrate-Rich Meal on Glucose Homeostasis in People without Diabetes after Roux-en-Y Gastric Bypass: a Proof-of-Concept, Randomized, Open-Label, Crossover Study
Introduction: Roux-en-Y gastric bypass (RYGB) induces substantial weight loss and changes in glucose homeostasis, partly through alterations in gastrointestinal anatomy and nutrient absorption. Sodium-glucose co-transporters-1 (SGLT-1) facilitate intestinal glucose absorption, a process that may be compromised post-RYGB. Animal studies suggest that sodium supplementation to a meal may enhance SGLT-1 activity post-RYGB. In this study, we investigated whether adding sodium chloride (NaCl) to a carbohydrate-rich meal affects glucose homeostasis in people after RYGB. Methods: In this open-label, randomized, crossover study, eleven adults without diabetes post-RYGB (mean age 57.3 ± 11.3 years, BMI 35.1 ± 7.5 kg/m2, 64% female) underwent two mixed meal tolerance tests (MMTT), on separate days, either with or without 2 g of additional NaCl (785 mg sodium). The primary outcome was the difference in nadir postprandial plasma glucose between conditions. Secondary outcomes included differences in area under the curve (AUC 0 − 180‘ ), fasting and peak plasma glucose, insulin, c-peptide and glucagon-like peptide-1 (GLP-1) concentrations. Results: The addition of 2 g NaCl did not alter nadir plasma glucose (3.7 mmol/L with NaCl vs 3.5 mmol/L without NaCl, 95% CI: -0.50 to 0.30, p = 0.55), fasting glucose or AUC 0 − 180’ glucose. However, peak plasma glucose was lower with NaCl (7.8 vs 8.3 mmol/L, 95% CI: -0.88 to -0.08, p = 0.02). No differences were observed in AUC 0 − 180’ , fasting and peak insulin, c-peptide and GLP-1 concentrations between the conditions. Conclusions: In individuals post-RYGB without diabetes, sodium supplementation during a carbohydrate-rich meal did not substantially affect glucose homeostasis, although it appeared to reduce peak postprandial plasma glucose. Further studies are warranted to explore the clinical relevance of this effect.
- Open Access
Clinical Outcomes of Passive Sensors in Remote Monitoring: A Systematic Review
Remote monitoring technologies have transformed healthcare delivery by enabling the in-home management of chronic conditions, improving patient autonomy, and supporting clinical oversight. Passive sensing, a subset of remote monitoring, facilitates unobtrusive, real-time data collection without active user engagement. Leveraging devices such as smartphones, wearables, and smart home sensors, these technologies offer advantages over traditional self-reports and intermittent evaluations by capturing behavioural, physiological, and environmental metrics. This systematic review evaluates the clinical utility of passive sensing technologies used in remote monitoring, with a specific emphasis on their impact on clinical outcomes and feasibility in real-world healthcare settings. A PRISMA-guided search identified 26 studies addressing conditions such as Parkinson’s disease, dementia, cancer, cardiopulmonary disorders, and musculoskeletal issues. Findings demonstrated significant correlations between sensor-derived metrics and clinical assessments, validating their potential as digital biomarkers. These technologies demonstrated feasibility and ecological validity in capturing continuous, real-world health data and offer a unified framework for enhancing patient care through three main applications: monitoring chronic disease progression, detecting acute health deterioration, and supporting therapeutic interventions. For example, these technologies successfully identified gait speed changes in Parkinson’s disease, tracked symptom fluctuations in cancer patients, and provided real-time alerts for acute events such as heart failure decompensation. Challenges included long-term adherence, scalability, data integration, security, and ownership. Future research should prioritise validation across diverse settings, long-term impact assessment, and integration into clinical workflows to maximise their utility.
Open AccessClinical Outcomes of Passive Sensors in Remote Monitoring: A Systematic Review
Remote monitoring technologies have transformed healthcare delivery by enabling the in-home management of chronic conditions, improving patient autonomy, and supporting clinical oversight. Passive sensing, a subset of remote monitoring, facilitates unobtrusive, real-time data collection without active user engagement. Leveraging devices such as smartphones, wearables, and smart home sensors, these technologies offer advantages over traditional self-reports and intermittent evaluations by capturing behavioural, physiological, and environmental metrics. This systematic review evaluates the clinical utility of passive sensing technologies used in remote monitoring, with a specific emphasis on their impact on clinical outcomes and feasibility in real-world healthcare settings. A PRISMA-guided search identified 26 studies addressing conditions such as Parkinson’s disease, dementia, cancer, cardiopulmonary disorders, and musculoskeletal issues. Findings demonstrated significant correlations between sensor-derived metrics and clinical assessments, validating their potential as digital biomarkers. These technologies demonstrated feasibility and ecological validity in capturing continuous, real-world health data and offer a unified framework for enhancing patient care through three main applications: monitoring chronic disease progression, detecting acute health deterioration, and supporting therapeutic interventions. For example, these technologies successfully identified gait speed changes in Parkinson’s disease, tracked symptom fluctuations in cancer patients, and provided real-time alerts for acute events such as heart failure decompensation. Challenges included long-term adherence, scalability, data integration, security, and ownership. Future research should prioritise validation across diverse settings, long-term impact assessment, and integration into clinical workflows to maximise their utility.
- 4 April 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (5) , 1800-1807
Disparities in Complication Rates Among Ethnic Minorities Undergoing Bariatric Surgery in the UK
Background Ethnicity may play a significant role in determining surgical outcomes. This study examines the disease profiles across ethnic groups and investigates whether ethnicity influences the risk of complications following bariatric surgery. Methods Data from the United Kingdom’s National Bariatric Surgery Registry (NBSR) were analysed, encompassing all adult patients undergoing bariatric procedures. Comparative analyses were performed, and a multivariable regression model was developed to identify factors associated with postoperative complications. Results A total of 77,710 (78.8% female) patients were included in the analysis, with a median age of 46 (IQR 37–55) years. Most patients were Caucasian (91.6%), followed by Asian (4.1%), Afro-Caribbean (2.5%), and African (1.7%) groups. Afro-Caribbean patients had the highest median BMI (44.5 kg/m2) and the highest prevalence of hypertension (43.2%), while Asian patients were younger (median age 41 years) and had a higher prevalence of diabetes mellitus (29.1%). African and Afro-Caribbean patients were less likely to self-fund their procedures (14.9% and 10.6%, respectively) compared to Caucasians (25.9%). Complication rates were the highest among Afro-Caribbean patients (5.8 vs 4.8%, p < 0.001) compared to Caucasians. Multivariable regression analysis identified ethnicity as an independent predictor of postoperative complications, with Afro-Caribbean (OR 1.47, 95% CI 1.22–1.87, p < 0.001) and African (OR 1.34, 95% CI 1.05–1.70, p = 0.019) patients demonstrating significantly increased risks. Conclusions This registry analysis identified ethnic disparities in disease profiles and postoperative outcomes among bariatric surgery patients in the UK, underscoring the need for targeted health policies to improve outcomes in these vulnerable populations.
- 4 April 2025
- Published by Springer Nature in Obesity Surgery
- Vol. 35 (5) , 1800-1807
Disparities in Complication Rates Among Ethnic Minorities Undergoing Bariatric Surgery in the UK
Background Ethnicity may play a significant role in determining surgical outcomes. This study examines the disease profiles across ethnic groups and investigates whether ethnicity influences the risk of complications following bariatric surgery. Methods Data from the United Kingdom’s National Bariatric Surgery Registry (NBSR) were analysed, encompassing all adult patients undergoing bariatric procedures. Comparative analyses were performed, and a multivariable regression model was developed to identify factors associated with postoperative complications. Results A total of 77,710 (78.8% female) patients were included in the analysis, with a median age of 46 (IQR 37–55) years. Most patients were Caucasian (91.6%), followed by Asian (4.1%), Afro-Caribbean (2.5%), and African (1.7%) groups. Afro-Caribbean patients had the highest median BMI (44.5 kg/m2) and the highest prevalence of hypertension (43.2%), while Asian patients were younger (median age 41 years) and had a higher prevalence of diabetes mellitus (29.1%). African and Afro-Caribbean patients were less likely to self-fund their procedures (14.9% and 10.6%, respectively) compared to Caucasians (25.9%). Complication rates were the highest among Afro-Caribbean patients (5.8 vs 4.8%, p < 0.001) compared to Caucasians. Multivariable regression analysis identified ethnicity as an independent predictor of postoperative complications, with Afro-Caribbean (OR 1.47, 95% CI 1.22–1.87, p < 0.001) and African (OR 1.34, 95% CI 1.05–1.70, p = 0.019) patients demonstrating significantly increased risks. Conclusions This registry analysis identified ethnic disparities in disease profiles and postoperative outcomes among bariatric surgery patients in the UK, underscoring the need for targeted health policies to improve outcomes in these vulnerable populations.
- Open Access
- 20 March 2025
- Published by Wolters Kluwer Health in International Journal of Surgery Protocols
- Vol. 29 (2) , 63-67
National Emergency Bariatric Surgical Audit (NEBSA): a protocol for a multi-center prospective study of unplanned interventions following emergency bariatric surgery
Introduction: The advent of bariatric surgery as a widespread intervention is paralleled by comprehensive data capture in bariatric registries following elective surgery. However, significant challenges hinder tracking the incidence and nature of severe complications in the context of bariatric surgery. As the prevalence of bariatric procedures escalates, the establishment of a dedicated, prospective complication registry becomes imperative. Such an initiative would facilitate a nuanced understanding of bariatric surgical emergency (BSE) within the current healthcare milieu, enhance economic evaluations, elucidate long-term patient outcomes, and inform requisite adjustments in professional training. This study is designed to capture and assess the ramifications of emergency bariatric surgical practices within the United Kingdom. Methods and analysis: We propose a prospective, multi-center, audit of emergency bariatric surgical activity in all UK hospitals. Eligible participants are those who undergo any intervention or procedure (surgical or endoscopic) to diagnose or treat BSE. Primary outcome measures will include hospital length of stay, rates of complications (Clavien–Dindo), and 30-D mortality. Secondary outcomes will assess the broader impacts and patterns of care, including variations in practice and resource utilization across the nation, rates of outpatient follow-up, and the frequency of subsequent procedures (surgical or endoscopic) post-BSE. Additionally, the study will investigate potential predictors for patients’ choice between state-funded and self-pay bariatric surgery options, considering factors such as ethnicity and previous engagement with NHS-specialized weight loss pathways. Ethics and dissemination: This study will be registered as clinical audit at each participating hospital. The protocol will be disseminated through the British Obesity and Metabolic Surgery Society network and using a targeted social media-based strategy in the UK.
- 20 March 2025
- Published by Wolters Kluwer Health in International Journal of Surgery Protocols
- Vol. 29 (2) , 63-67
Open AccessNational Emergency Bariatric Surgical Audit (NEBSA): a protocol for a multi-center prospective study of unplanned interventions following emergency bariatric surgery
Introduction: The advent of bariatric surgery as a widespread intervention is paralleled by comprehensive data capture in bariatric registries following elective surgery. However, significant challenges hinder tracking the incidence and nature of severe complications in the context of bariatric surgery. As the prevalence of bariatric procedures escalates, the establishment of a dedicated, prospective complication registry becomes imperative. Such an initiative would facilitate a nuanced understanding of bariatric surgical emergency (BSE) within the current healthcare milieu, enhance economic evaluations, elucidate long-term patient outcomes, and inform requisite adjustments in professional training. This study is designed to capture and assess the ramifications of emergency bariatric surgical practices within the United Kingdom. Methods and analysis: We propose a prospective, multi-center, audit of emergency bariatric surgical activity in all UK hospitals. Eligible participants are those who undergo any intervention or procedure (surgical or endoscopic) to diagnose or treat BSE. Primary outcome measures will include hospital length of stay, rates of complications (Clavien–Dindo), and 30-D mortality. Secondary outcomes will assess the broader impacts and patterns of care, including variations in practice and resource utilization across the nation, rates of outpatient follow-up, and the frequency of subsequent procedures (surgical or endoscopic) post-BSE. Additionally, the study will investigate potential predictors for patients’ choice between state-funded and self-pay bariatric surgery options, considering factors such as ethnicity and previous engagement with NHS-specialized weight loss pathways. Ethics and dissemination: This study will be registered as clinical audit at each participating hospital. The protocol will be disseminated through the British Obesity and Metabolic Surgery Society network and using a targeted social media-based strategy in the UK.
- Open Access
- 23 September 2024
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (12) , 7404-7413
National introduction of one-anastomosis gastric bypass in the UK National Bariatric Surgery Registry: a cohort study
Aim: There is a paucity of evidence regarding the national introduction of newer bariatric metabolic surgery procedures. This study assessed the impact of introducing one-anastomosis gastric bypass (OAGB) in bariatric surgical practice in the UK on 30-day postoperative morbidity and early postoperative weight loss. Methods: Patients who underwent primary BMS in the UK National Bariatric Surgical Registry (2010–2019) were identified. Patient characteristics, 30-day postoperative morbidity, and 12-month total body weight loss (TBWL) were also assessed. Multivariate regression was performed for associations between 30-day postoperative morbidity and 12-month TBWL, with SG as a reference. Learning effects were assessed by factoring in the institutional OAGB caseload (0–24/25–49/50+ cases). Results: A total of 59 226 patients underwent primary BMS during the study period (RYGB, 38 434; SG, 24 702; AGB, 12 627; OAGB, 3408; and others, 276). The 30-day postoperative morbidity was lower for OAGB 1.8% (51/2802) compared to RYGB 4.2% (1391/32 853) and SG 3.4% (725/21 333) but higher than AGB 1.2% (123/9915), while on multivariate regression, OAGB was associated with reduced morbidity once the institution caseload exceeded 50 operations (OR 0.35 (95% CI: 0.22–0.56; PP<0.001). Conclusion: OAGB has been safely implemented in UK national bariatric surgery practice. It has lower reported postoperative morbidity and comparable weight loss to RYGB or SG, despite being offered to patients with more severe and complex obesity.
- 23 September 2024
- Published by Wolters Kluwer Health in International Journal of Surgery
- Vol. 110 (12) , 7404-7413
Open AccessNational introduction of one-anastomosis gastric bypass in the UK National Bariatric Surgery Registry: a cohort study
Aim: There is a paucity of evidence regarding the national introduction of newer bariatric metabolic surgery procedures. This study assessed the impact of introducing one-anastomosis gastric bypass (OAGB) in bariatric surgical practice in the UK on 30-day postoperative morbidity and early postoperative weight loss. Methods: Patients who underwent primary BMS in the UK National Bariatric Surgical Registry (2010–2019) were identified. Patient characteristics, 30-day postoperative morbidity, and 12-month total body weight loss (TBWL) were also assessed. Multivariate regression was performed for associations between 30-day postoperative morbidity and 12-month TBWL, with SG as a reference. Learning effects were assessed by factoring in the institutional OAGB caseload (0–24/25–49/50+ cases). Results: A total of 59 226 patients underwent primary BMS during the study period (RYGB, 38 434; SG, 24 702; AGB, 12 627; OAGB, 3408; and others, 276). The 30-day postoperative morbidity was lower for OAGB 1.8% (51/2802) compared to RYGB 4.2% (1391/32 853) and SG 3.4% (725/21 333) but higher than AGB 1.2% (123/9915), while on multivariate regression, OAGB was associated with reduced morbidity once the institution caseload exceeded 50 operations (OR 0.35 (95% CI: 0.22–0.56; PP<0.001). Conclusion: OAGB has been safely implemented in UK national bariatric surgery practice. It has lower reported postoperative morbidity and comparable weight loss to RYGB or SG, despite being offered to patients with more severe and complex obesity.
- 2 March 2024
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 111 (3)
Characterizing barriers and facilitators of metabolic bariatric surgery tourism: a systematic review
Background: Metabolic bariatric surgery tourism continues to rise and has become a growing concern for bariatric surgeons globally. With varying degrees of regulation, counselling and success, those that develop complications may have to deal with a multitude of challenges often distant from their country of operation. The aim of this study was to characterize the barriers and facilitators influencing individuals to undergo metabolic bariatric surgery tourism, in order to better understand the implications to the National Health Service and other healthcare systems. Methods: A systematic literature search, restricted to the English language, was performed to identify relevant studies. All studies were included until December 2022, the last search date. Study quality was assessed with the validated mixed-methods appraisal tool. A Braun and Clarke thematic analysis was undertaken to identify themes and subthemes. Results: A total of five studies met the inclusion criteria. Identified themes included: availability, accessibility, cost, eligibility, reputation, and stigma; the available evidence was of varying quality. Conclusion: This work identifies a series of subthemes influencing the decision to undertake metabolic bariatric surgery tourism. The results highlight the limited literature available in understanding the complex motivational insights; the scale of the problem in the current healthcare system; cost and long-term outcomes. A National Emergency Bariatric Surgery audit would allow generation of more robust data to explore further the issues of clinical relationships and networks and to guide policy making.
- 2 March 2024
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 111 (3)
Characterizing barriers and facilitators of metabolic bariatric surgery tourism: a systematic review
Background: Metabolic bariatric surgery tourism continues to rise and has become a growing concern for bariatric surgeons globally. With varying degrees of regulation, counselling and success, those that develop complications may have to deal with a multitude of challenges often distant from their country of operation. The aim of this study was to characterize the barriers and facilitators influencing individuals to undergo metabolic bariatric surgery tourism, in order to better understand the implications to the National Health Service and other healthcare systems. Methods: A systematic literature search, restricted to the English language, was performed to identify relevant studies. All studies were included until December 2022, the last search date. Study quality was assessed with the validated mixed-methods appraisal tool. A Braun and Clarke thematic analysis was undertaken to identify themes and subthemes. Results: A total of five studies met the inclusion criteria. Identified themes included: availability, accessibility, cost, eligibility, reputation, and stigma; the available evidence was of varying quality. Conclusion: This work identifies a series of subthemes influencing the decision to undertake metabolic bariatric surgery tourism. The results highlight the limited literature available in understanding the complex motivational insights; the scale of the problem in the current healthcare system; cost and long-term outcomes. A National Emergency Bariatric Surgery audit would allow generation of more robust data to explore further the issues of clinical relationships and networks and to guide policy making.
- 19 January 2024
- Published by Springer Nature in Obesity Surgery
- Vol. 34 (3) , 967-975
Systematic Review and Meta-analysis of the Effects of Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy on Dyslipidemia
The aim of this meta-analysis was to compare the effects of LRYGB and LSG on dyslipidemia. Studies comparing the effects of LRYGB and LSG on dyslipidemia with follow-up of 12 months or more were included. Twenty-four studies comprising seven RCTs and 17 comparative observational studies were included. Meta-analysis of RCTs (n=487) showed that improvement/resolution of dyslipidemia was better after LRYGB (68.5%, n=161/235) compared to LSG (48.4%, n=122/252). Patients undergoing LRYGB were more than twice as likely to experience improvement/resolution in dyslipidemia compared to those undergoing LSG (OR 2.28, 95% CI 1.21–4.29, p=0.010). Both LRGYB and LSG appears effective in improving dyslipidemia at >12 months after surgery; however, this improvement is more than twice higher after LRYGB compared to LSG.
- 19 January 2024
- Published by Springer Nature in Obesity Surgery
- Vol. 34 (3) , 967-975
Systematic Review and Meta-analysis of the Effects of Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy on Dyslipidemia
The aim of this meta-analysis was to compare the effects of LRYGB and LSG on dyslipidemia. Studies comparing the effects of LRYGB and LSG on dyslipidemia with follow-up of 12 months or more were included. Twenty-four studies comprising seven RCTs and 17 comparative observational studies were included. Meta-analysis of RCTs (n=487) showed that improvement/resolution of dyslipidemia was better after LRYGB (68.5%, n=161/235) compared to LSG (48.4%, n=122/252). Patients undergoing LRYGB were more than twice as likely to experience improvement/resolution in dyslipidemia compared to those undergoing LSG (OR 2.28, 95% CI 1.21–4.29, p=0.010). Both LRGYB and LSG appears effective in improving dyslipidemia at >12 months after surgery; however, this improvement is more than twice higher after LRYGB compared to LSG.
- Open Access
- 1 August 2023
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 11 (10) , 373
Limitations concerning evaluation of the current guidelines using the Appraisal of Guidelines Research and Evaluation II
Limitations concerning evaluation of the current guidelines using the Appraisal of Guidelines Research and Evaluation II
- 1 August 2023
- Published by AME Publishing Company in Annals of Translational Medicine
- Vol. 11 (10) , 373
Open AccessLimitations concerning evaluation of the current guidelines using the Appraisal of Guidelines Research and Evaluation II
Limitations concerning evaluation of the current guidelines using the Appraisal of Guidelines Research and Evaluation II
- Open Access
- 31 July 2023
- Published by Elsevier in Clinical Medicine
- Vol. 23 (4) , 330-336
The surgical management of obesity
Obesity has reached pandemic levels globally. Surgical management of obesity aims to establish metabolic control, weight loss and resolution of multiple health conditions and to improve quality of life. Here, we examine the role of surgery in the management of obesity within the context of a multidisciplinary team involving a variety of healthcare professionals. We highlight the importance of patient selection, perioperative care, the various types of bariatric surgery currently available as well as emerging procedures. In addition to clarifying the different types of procedure, we also examine the potential complications and issues of weight regain and failure to lose weight. Ultimately, bariatric surgery remains comparatively safe and with generally excellent results in terms of control of existing obesity-related conditions; with the ever-increasing number of patients living with obesity, the scope of bariatric surgery is thus likely to increase.
- 31 July 2023
- Published by Elsevier in Clinical Medicine
- Vol. 23 (4) , 330-336
Open AccessThe surgical management of obesity
Obesity has reached pandemic levels globally. Surgical management of obesity aims to establish metabolic control, weight loss and resolution of multiple health conditions and to improve quality of life. Here, we examine the role of surgery in the management of obesity within the context of a multidisciplinary team involving a variety of healthcare professionals. We highlight the importance of patient selection, perioperative care, the various types of bariatric surgery currently available as well as emerging procedures. In addition to clarifying the different types of procedure, we also examine the potential complications and issues of weight regain and failure to lose weight. Ultimately, bariatric surgery remains comparatively safe and with generally excellent results in terms of control of existing obesity-related conditions; with the ever-increasing number of patients living with obesity, the scope of bariatric surgery is thus likely to increase.
- 28 June 2023
- Published by ABCD Diabetes Care, Ltd. in British Journal of Diabetes
- Vol. 23 (1) , 31-34
Association between preoperative glucose- lowering medication agents and the status of type 2 diabetes mellitus after bariatric surgery
Introduction: Bariatric surgery is an effective treatment for type 2 diabetes mellitus (T2DM) in patients with morbid obesity. This study investigates whether duration of diabetes and anti-diabetes therapy are associated with glycaemic control after surgery in a routine clinical setting. Method: A cohort analysis of a prospectively maintained database was carried out for consecutive bariatric operations performed between April 2017 and March 2018 for patients with T2DM. Results: A total 105 patients with T2DM underwent bariatric surgery (89 Roux-en-Y gastric bypass and 16 sleeve gastrectomy). Median follow-up was 19 months ([interquartile range] IQR 13-24 months). Median weight and body mass index (BMI) on the day of surgery were 125 kg (IQR 103.9- 138.7) and 42.4 kg/m2 (IQR 39-46.8), respectively. At follow- up, 68 patients (64.8%) had achieved remission of diabetes. Patients who were pre-operatively on more than one glucose-lowering medication were less likely to go into remission (odds ratio [OR] 0.13, 95% CI 0.04-0.44, p=0.001) compared to those that were on a single glucose-lowering medication agent. Pre-operative use of insulin therapy (OR 0.09, 95% CI 0.03-0.31, p= Conclusions: Most patients who are medicated for T2DM can stop their glucose-lowering medication after bariatric surgery. Patients who are on multiple glucose-lowering medication agents or those dependent on insulin or SGLT2 inhibitors before bariatric surgery are less likely to undergo complete remission >12 months after bariatric surgery.
- 28 June 2023
- Published by ABCD Diabetes Care, Ltd. in British Journal of Diabetes
- Vol. 23 (1) , 31-34
Association between preoperative glucose- lowering medication agents and the status of type 2 diabetes mellitus after bariatric surgery
Introduction: Bariatric surgery is an effective treatment for type 2 diabetes mellitus (T2DM) in patients with morbid obesity. This study investigates whether duration of diabetes and anti-diabetes therapy are associated with glycaemic control after surgery in a routine clinical setting. Method: A cohort analysis of a prospectively maintained database was carried out for consecutive bariatric operations performed between April 2017 and March 2018 for patients with T2DM. Results: A total 105 patients with T2DM underwent bariatric surgery (89 Roux-en-Y gastric bypass and 16 sleeve gastrectomy). Median follow-up was 19 months ([interquartile range] IQR 13-24 months). Median weight and body mass index (BMI) on the day of surgery were 125 kg (IQR 103.9- 138.7) and 42.4 kg/m2 (IQR 39-46.8), respectively. At follow- up, 68 patients (64.8%) had achieved remission of diabetes. Patients who were pre-operatively on more than one glucose-lowering medication were less likely to go into remission (odds ratio [OR] 0.13, 95% CI 0.04-0.44, p=0.001) compared to those that were on a single glucose-lowering medication agent. Pre-operative use of insulin therapy (OR 0.09, 95% CI 0.03-0.31, p= Conclusions: Most patients who are medicated for T2DM can stop their glucose-lowering medication after bariatric surgery. Patients who are on multiple glucose-lowering medication agents or those dependent on insulin or SGLT2 inhibitors before bariatric surgery are less likely to undergo complete remission >12 months after bariatric surgery.